These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18845793)

  • 1. Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes.
    Tiedt R; Coers J; Ziegler S; Wiestner A; Hao-Shen H; Bornmann C; Schenkel J; Karakhanova S; de Sauvage FJ; Jackson CW; Skoda RC
    Blood; 2009 Feb; 113(8):1768-77. PubMed ID: 18845793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.
    Lannutti BJ; Epp A; Roy J; Chen J; Josephson NC
    Blood; 2009 Feb; 113(8):1778-85. PubMed ID: 18796624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.
    Ng AP; Kauppi M; Metcalf D; Hyland CD; Josefsson EC; Lebois M; Zhang JG; Baldwin TM; Di Rago L; Hilton DJ; Alexander WS
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5884-9. PubMed ID: 24711413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
    Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
    J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.
    Lorenz V; Ramsey H; Liu ZJ; Italiano J; Hoffmeister K; Bihorel S; Mager D; Hu Z; Slayton WB; Kile BT; Sola-Visner M; Ferrer-Marin F
    Thromb Haemost; 2017 Dec; 117(12):2322-2333. PubMed ID: 29212120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Cbl regulates c-MPL receptor trafficking and its internalization.
    Märklin M; Tandler C; Kopp HG; Hoehn KL; Quintanilla-Martinez L; Borst O; Müller MR; Saur SJ
    J Cell Mol Med; 2020 Nov; 24(21):12491-12503. PubMed ID: 32954656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.
    Deutsch VR; Tomer A
    Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
    Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
    Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic mice overexpressing human c-mpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5-fluorouracil or antiplatelet serum treatment.
    Zhou W; Toombs CF; Zou T; Guo J; Robinson MO
    Blood; 1997 Mar; 89(5):1551-9. PubMed ID: 9057636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of promoter element in c-mpl gene expression induced by TPO.
    Sunohara M; Morikawa S; Fuse A; Sato I
    Okajimas Folia Anat Jpn; 2013; 89(4):131-5. PubMed ID: 23614986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin from beginning to end.
    Hitchcock IS; Kaushansky K
    Br J Haematol; 2014 Apr; 165(2):259-68. PubMed ID: 24499199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
    Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
    Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Megakaryopoiesis: regulation of platelet production by thrombopoietin].
    Vainchenker W; Besancenot R; Favale F
    Bull Acad Natl Med; 2013 Feb; 197(2):395-406. PubMed ID: 24919369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis.
    Marty C; Pecquet C; Nivarthi H; El-Khoury M; Chachoua I; Tulliez M; Villeval JL; Raslova H; Kralovics R; Constantinescu SN; Plo I; Vainchenker W
    Blood; 2016 Mar; 127(10):1317-24. PubMed ID: 26608331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production.
    Gainsford T; Roberts AW; Kimura S; Metcalf D; Dranoff G; Mulligan RC; Begley CG; Robb L; Alexander WS
    Blood; 1998 Apr; 91(8):2745-52. PubMed ID: 9531584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.
    Geddis AE; Fox NE; Kaushansky K
    Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.
    Besancenot R; Roos-Weil D; Tonetti C; Abdelouahab H; Lacout C; Pasquier F; Willekens C; Rameau P; Lecluse Y; Micol JB; Constantinescu SN; Vainchenker W; Solary E; Giraudier S
    Blood; 2014 Sep; 124(13):2104-15. PubMed ID: 25143485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia.
    Horikawa Y; Matsumura I; Hashimoto K; Shiraga M; Kosugi S; Tadokoro S; Kato T; Miyazaki H; Tomiyama Y; Kurata Y; Matsuzawa Y; Kanakura Y
    Blood; 1997 Nov; 90(10):4031-8. PubMed ID: 9354672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytopenia in c-mpl-deficient mice.
    Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
    Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106L.
    Favale F; Messaoudi K; Varghese LN; Boukour S; Pecquet C; Gryshkova V; Defour JP; Albu RI; Bluteau O; Ballerini P; Leverger G; Plo I; Debili N; Raslova H; Favier R; Constantinescu SN; Vainchenker W
    Blood; 2016 Dec; 128(26):3146-3158. PubMed ID: 28034873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.